secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2024-08-20T23:59:59+00:00
Accession:  0001193125-24-203149
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex calls warrants after positive Alzheimer's trial FDG-PET signal
-----------------------------------------------------------------------

- Warrants from Oct/Nov 2023, Feb/Mar 2024 financings called for cancellation at $0.0001/share.
- Call triggered by statistically significant increase in FDG-PET signal in SIGNAL-AD pepinemab trial.
- Warrant holders have 20 or 30 trading days to exercise; unexercised warrants auto-cancel.
- Company plans to explore additional financing options, including warrant inducement or exchange.
- No guarantee of warrant exercise or success of any potential financing transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524203149/0001193125-24-203149-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524203149/d867905d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-203149

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer